BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34369368)

  • 41. Back pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based study.
    Lindström U; Bremander A; Haglund E; Bergman S; Petersson IF; Jacobsson LT
    BMC Musculoskelet Disord; 2016 Feb; 17():106. PubMed ID: 26922375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study.
    Fagerli KM; van der Heijde D; Heiberg MS; Wierød A; Kalstad S; Rødevand E; Mikkelsen K; Kvien TK; Lie E
    Rheumatology (Oxford); 2014 Jun; 53(6):1087-94. PubMed ID: 24501243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study.
    Zabotti A; Luchetti MM; Selmi CF; Ramonda R; Grembiale RD; Dagna L; D'Angelo S; Cafaro G; De Vita S; Felicetti M; Marelli S; Frigerio D; Favalli EG
    Front Med (Lausanne); 2021; 8():711875. PubMed ID: 34631733
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of a special concept of physical therapy in spondyloarthritis: German multimodal rheumatologic complex treatment for spondyloarthritis.
    Klemm P; Hudowenz O; Asendorf T; Dischereit G; Müller-Ladner U; Lange U; Tarner IH
    Clin Rheumatol; 2020 May; 39(5):1513-1520. PubMed ID: 31916106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A community-based study on the prevalence of spondyloarthritis and inflammatory back pain in Mexicans.
    Peláez-Ballestas I; Navarro-Zarza JE; Julian B; Lopez A; Flores-Camacho R; Casasola-Vargas JC; Sanin LH; Rivas L; Vázquez-Mellado J; Burgos-Vargas R
    J Clin Rheumatol; 2013 Mar; 19(2):57-61. PubMed ID: 23425667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
    Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G
    Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of Comorbidities and Risk Factors for Comorbidities in Patients with Spondyloarthritis in Latin America: A Comparative Study with the General Population and Data from the ASAS-COMOSPA Study.
    Bautista-Molano W; Landewé R; Burgos-Vargas R; Maldonado-Cocco J; Moltó A; van den Bosch F; Valle-Oñate R; Dougados M; van der Heijde D
    J Rheumatol; 2018 Feb; 45(2):206-212. PubMed ID: 29247152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
    Simone D; Nowik M; Gremese E; Ferraccioli GF
    J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis.
    Braun J; Inman R
    Ann Rheum Dis; 2010 Jul; 69(7):1264-8. PubMed ID: 20566619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain?
    Braun A; Saracbasi E; Grifka J; Schnitker J; Braun J
    Ann Rheum Dis; 2011 Oct; 70(10):1782-7. PubMed ID: 21821621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study.
    Stolwijk C; Essers I; van den Bosch F; Dougados M; Etcheto A; van der Heijde D; Landewé R; Molto A; van Tubergen A; Boonen A;
    Rheumatology (Oxford); 2020 Jul; 59(7):1632-1639. PubMed ID: 31665462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxicological considerations in the treatment of axial spondylo-arthritis.
    Marino F; D'Angelo S; Masala IF; Gerratana E; Nucera V; La Corte L; Giallanza M; Sarzi-Puttini P; Atzeni F
    Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):663-672. PubMed ID: 32552128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An epidemiological study of the prevalence rate of inflammatory back pain and axial spondyloarthritis in a university in the south of China.
    Tong F; Lv Q; Li A; Fang L; Luo Z; Feng J; Gu J; Lin Z
    Clin Rheumatol; 2018 Nov; 37(11):3087-3091. PubMed ID: 29974281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study.
    Bengtsson K; Forsblad-d'Elia H; Deminger A; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
    Rheumatology (Oxford); 2021 Jun; 60(6):2725-2734. PubMed ID: 33216939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases.
    Rivière E; Arnaud L; Ebbo M; Allanore Y; Claudepierre P; Dernis E; Ziza JM; Miceli-Richard C; Philippe P; Richez C; Soubrier M; Belkhir R; Seror R; Mariette X; Pavy S;
    J Rheumatol; 2017 Jul; 44(7):1011-1017. PubMed ID: 28412700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of treatment options for spondyloarthritis: a narrative review.
    D'Angelo S; Carriero A; Gilio M; Ursini F; Leccese P; Palazzi C
    Expert Opin Drug Saf; 2018 May; 17(5):475-486. PubMed ID: 29505325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and sonographic discrimination between fibromyalgia and spondyloarthopathy in inflammatory bowel disease with musculoskeletal pain.
    Martinis F; Tinazzi I; Bertolini E; Citriniti G; Variola A; Geccherle A; Marchetta A; McGonagle D; Macchioni P
    Rheumatology (Oxford); 2020 Oct; 59(10):2857-2863. PubMed ID: 32068873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials.
    Curtis JR; Mariette X; Gaujoux-Viala C; Blauvelt A; Kvien TK; Sandborn WJ; Winthrop K; de Longueville M; Huybrechts I; Bykerk VP
    RMD Open; 2019; 5(1):e000942. PubMed ID: 31245056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapy for spondyloarthritis: the role of extra-articular manifestations (eye, skin).
    Carron P; Van Praet L; Jacques P; Elewaut D; Van den Bosch F
    Rheum Dis Clin North Am; 2012 Aug; 38(3):583-600. PubMed ID: 23083757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.